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Genetic variability of influenza virus and vaccine effectiveness 
 
 
Background 
Euroeva is the portuguese component of the multicentric study I-MOVE (influenza 
monitoring vaccine effectiveness in Europe) that aims to estimate influenza vaccine 
effectiveness in Europe.  
As an higher VE is expected when circulating viruses are similar to the vaccine strains, 
this study aims to describe circulating strains and amino acid substitutions in antigenic 
sites in order to better understand VE changes along seasons. 
 
 
Methods 
For this study, we used laboratory surveillance data from the last five seasons and VE 
estimated by EuroEVA that uses the test negative design.  
Reference laboratory to influenza performed genetic characterization by phylogenetic 
analysis of the subunit 1 of haemaglutinin gene.   
 
Results 
Overall VE was low to moderate in all studied seasons. Higher VE was observed when 
Influenza B circulated which is in line with the higher VE estimated for Influenza B in 
all studied seasons, even when several amino acid substitutions in antigenic sites were 
observed. 
Sub-optimal VE was estimated when Influenza A(H3) was dominant  or co-dominant. 
The lowest VE was observed against influenza A(H3) in the last season. 
Also low VE was estimated against Influenza A(H1)pdm09.  
For both subtypes of influenza A the acquisition of substitutions in antigenic sites that 
correlates with higher differences when comparing with vaccine strains was observed.  
 
 
Conclusions 
For influenza B, VE was always higher than for influenza A, even when the circulating 
lineage was different from the vaccine selected virus and the acquisition of mutations in 
influenza B viruses had a moderate effect in decreasing VE. This fact could be 
explained by the cross-immunity between different influenza B strains. VE for 
A(H1)pdm09 did not reflect their genetic variability maybe because they remained 
antigenically similar to the vaccine strains  but for A(H3) a dramatically reduction in 
VE was observed in last season when the drift virus dissimilar to the vaccine strain 
circulated.  
Antigenic and genetic characteristics of circulating viruses are an important clue for VE 
prediction and interpretation, however there are individual immunological factors as 
cellular immunity and waning immunity that should be considered. 
